Dormosedan Gel
دورموسيدان جل
Dormosedan Gel (detomidine hydrochloride) is an alpha-2 adrenoceptor agonist formulated as an oral transmucosal gel for mild standing sedation and restraint in horses to facilitate non-painful husbandry and minor veterinary procedures.
Dosage Form
Gel
Product Type
Pharmaceutical
Manufacturer
Package
3.0 mL prefilled oral dial-a-dose syringe containing 7.6 mg/mL detomidine hydrochloride
Dosages
| Species | Dosage | Route | Duration |
|---|---|---|---|
| Horse | 0.040 mg/kg (0.012 mL/kg) body weight sublingually | Oral transmucosal (Sublingual) | Single dose; provides sedation lasting 90 to 180 minutes |
Withdrawal Periods
| Species | Meat (days) | Milk (days) | Eggs (days) |
|---|---|---|---|
| Horse | 3 |
Indications
-
Mild standing sedation and restraint to facilitate non-painful minor veterinary, dental, and husbandry procedures (such as shoeing, clipping, floating teeth, and clinical examinations) in horses.
Contraindications
-
Do not use in horses with preexisting severe cardiovascular disease, heart block, or bradycardia.
-
Do not use in horses with severe respiratory disorders or acute hepatic/renal failure.
-
Do not administer concurrently with intravenous potentiated sulfonamides.
Precautions
-
Sedated horses may appear completely asleep but retain response to sudden loud noises and defensive kicking.
-
Food and water should be withheld until sedation has completely dissipated to prevent esophageal choke or colic.
-
Impermeable gloves must be worn during administration to prevent human accidental dermal absorption.
Side Effects
-
Bradycardia, transient ataxia, penile relaxation/prolapse, mild sweating, muscle tremors, and transient hypertension followed by hypotension.
Images
Documents
-
Download
Dormosedan Gel Prescribing Information
Leaflet
Active Ingredients
Diseases
No diseases linked.
Related Products
No data available
Information has not been added yet.
Related Products By Active Ingredient
Companies
-
Zoetis
Manufacturer
Alternatives
No alternatives available.